Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Gross Profit (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Gross Profit for 9 consecutive years, with $589000.0 as the latest value for Q1 2019.

  • Quarterly Gross Profit rose 287.5% to $589000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Mar 2019, up 425.77% year-over-year, with the annual reading at $3.0 million for FY2018, 1973.97% up from the prior year.
  • Gross Profit for Q1 2019 was $589000.0 at Plus Therapeutics, down from $1.4 million in the prior quarter.
  • The five-year high for Gross Profit was $1.4 million in Q4 2018, with the low at -$125000.0 in Q1 2017.
  • Average Gross Profit over 5 years is $359705.9, with a median of $264000.0 recorded in 2015.
  • The sharpest move saw Gross Profit plummeted 117.7% in 2017, then surged 4641.38% in 2018.
  • Over 5 years, Gross Profit stood at $765000.0 in 2015, then tumbled by 31.9% to $521000.0 in 2016, then crashed by 94.43% to $29000.0 in 2017, then soared by 4641.38% to $1.4 million in 2018, then tumbled by 57.16% to $589000.0 in 2019.
  • According to Business Quant data, Gross Profit over the past three periods came in at $589000.0, $1.4 million, and $230000.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.